Study Clinical Feasibility of Cdk Iv Inhibitor for Pediatric Malignant Brain Tumors Treatment(1/3)

Project: A - Government Institution › b - National Science and Technology Council

Project Details

StatusFinished
Effective start/end date8/1/19 → 7/31/20

Keywords

  • Pediatric brain tumors
  • CDK4/6 inhibitors
  • Immunotherapy
  • PDX

Access Project